155 related articles for article (PubMed ID: 34909846)
1. SYNERGISTIC IMMUNOMODULATORY ACTIVITY OF PROBIOTICS BIFIDOBACTERIUM ANIMALIS AND LACTOBACILLUS CASEI IN ENTEROAGGREGATIVE ESCHERICHIA COLI (EAEC)-INFECTED CACO-2 CELLS.
Ferreira AF; Braga RLL; Andrade MF; Rosa ACP; Pereira-Manfro WF
Arq Gastroenterol; 2021; 58(4):433-438. PubMed ID: 34909846
[TBL] [Abstract][Full Text] [Related]
2. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88.
Roselli M; Finamore A; Britti MS; Mengheri E
Br J Nutr; 2006 Jun; 95(6):1177-84. PubMed ID: 16768842
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties.
Martins FS; Silva AA; Vieira AT; Barbosa FH; Arantes RM; Teixeira MM; Nicoli JR
Arch Microbiol; 2009 Aug; 191(8):623-30. PubMed ID: 19526225
[TBL] [Abstract][Full Text] [Related]
4. Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human β-defensin-2: dependence on inflammatory cytokines.
Habil N; Abate W; Beal J; Foey AD
Benef Microbes; 2014 Dec; 5(4):483-95. PubMed ID: 25116382
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory properties of probiotic bacteria on Salmonella-induced IL-8 synthesis in enterocyte-like Caco-2 cells.
Malago JJ; Tooten PC; Koninkx JF
Benef Microbes; 2010 Jun; 1(2):121-30. PubMed ID: 21840800
[TBL] [Abstract][Full Text] [Related]
6. Probiotic strains of lactobacilli and bifidobacteria alter pro- and anti-inflammatory cytokines production in rats with monosodium glutamate-induced obesity.
Falalyeyeva TM; Leschenko IV; Beregova TV; Lazarenko LM; Savchuk OM; Sichel LM; Tsyryuk OI; Vovk TB; Spivak MY
Fiziol Zh (1994); 2017; 63(1):17-25. PubMed ID: 29975824
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli.
Kumar M; Dhaka P; Vijay D; Vergis J; Mohan V; Kumar A; Kurkure NV; Barbuddhe SB; Malik SV; Rawool DB
Int J Antimicrob Agents; 2016 Sep; 48(3):265-70. PubMed ID: 27451088
[TBL] [Abstract][Full Text] [Related]
8. Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli.
Miyazaki Y; Kamiya S; Hanawa T; Fukuda M; Kawakami H; Takahashi H; Yokota H
J Infect Chemother; 2010 Feb; 16(1):10-8. PubMed ID: 20054601
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and antiadhesive effects of Lactobacillus isolates of healthy human gut origin on Enterotoxigenic Escherichia coli (ETEC) and Enteroaggregative Escherichia coli (EAEC).
Pazhoohan M; Sadeghi F; Moghadami M; Soltanmoradi H; Davoodabadi A
Microb Pathog; 2020 Nov; 148():104271. PubMed ID: 32835777
[TBL] [Abstract][Full Text] [Related]
10. Enteroaggregative Escherichia coli (EAEC) strains enter and survive within cultured intestinal epithelial cells.
Pereira AC; Britto-Filho JD; José de Carvalho J; de Luna Md; Rosa AC
Microb Pathog; 2008; 45(5-6):310-4. PubMed ID: 18674608
[TBL] [Abstract][Full Text] [Related]
11. Role of the YehD fimbriae in the virulence-associated properties of enteroaggregative Escherichia coli.
Soria-Bustos J; Saitz W; Medrano A; Lara-Ochoa C; Bennis Z; Monteiro-Neto V; Dos Santos CI; Rodrigues J; Hernandes RT; Yáñez JA; Torres J; Navarro-García F; Martínez-Laguna Y; Fontes Piazza RM; Munhoz DD; Cedillo ML; Ares MA; De la Cruz MA; Nataro JP; Girón JA
Environ Microbiol; 2022 Mar; 24(3):1035-1051. PubMed ID: 34431194
[TBL] [Abstract][Full Text] [Related]
12. INTRACELLULAR PERSISTENCE OF ENTEROAGGREGATIVE ESCHERICHIA COLI INDUCES A PROINFLAMMATORY CYTOKINES SECRETION IN INTESTINAL EPITHELIAL T84 CELLS.
Braga RLL; Pereira ACM; Ferreira AF; Rosa ACP; Pereira-Manfro WF
Arq Gastroenterol; 2018; 55(2):133-137. PubMed ID: 30043861
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Probiotics of
Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
[TBL] [Abstract][Full Text] [Related]
14. The Role of Fibronectin in the Adherence and Inflammatory Response Induced by Enteroaggregative
Yáñez D; Izquierdo M; Ruiz-Perez F; Nataro JP; Girón JA; Vidal RM; Farfan MJ
Front Cell Infect Microbiol; 2016; 6():166. PubMed ID: 28008386
[TBL] [Abstract][Full Text] [Related]
15. Mucin2 is Required for Probiotic Agents-Mediated Blocking Effects on Meningitic E. coli-Induced Pathogenicities.
Yu JY; He XL; Puthiyakunnon S; Peng L; Li Y; Wu LS; Peng WL; Zhang Y; Gao J; Zhang YY; Boddu S; Long M; Cao H; Huang SH
J Microbiol Biotechnol; 2015 Oct; 25(10):1751-60. PubMed ID: 26059517
[TBL] [Abstract][Full Text] [Related]
16. The influence of some probiotic supernatants on the growth and virulence features expression of several selected enteroaggregative E. coli clinical strains.
Lazăr V; Miyazaki Y; Hanawa T; Chifiriuc MC; Diţu LM; Măruţescu L; Bleotu C; Kamiya S
Roum Arch Microbiol Immunol; 2009; 68(4):207-14. PubMed ID: 20583474
[TBL] [Abstract][Full Text] [Related]
17. The different effects of probiotics treatment on Salmonella-induced interleukin-8 response in intestinal epithelia cells via PI3K/Akt and NOD2 expression.
Huang FC; Huang SC
Benef Microbes; 2016 Nov; 7(5):739-748. PubMed ID: 27680208
[TBL] [Abstract][Full Text] [Related]
18. A Novel Adult Murine Model of Typical Enteroaggregative
Moran-Garcia N; Lopez-Saucedo C; Becerra A; Meza-Segura M; Hernandez-Cazares F; Guerrero-Baez J; Galindo-Gómez S; Tsutsumi V; Schnoor M; Méndez-Tenorio A; Nataro JP; Estrada-Garcia T
Front Cell Infect Microbiol; 2022; 12():885191. PubMed ID: 35706909
[TBL] [Abstract][Full Text] [Related]
19. [Influence of Lactobacillus casei on biofilm formation by enteroaggregative Escherichia coli strains isolated from irritable bowel syndrome (IBS)].
Andrzejewska B; Sobieszczańska BM
Med Dosw Mikrobiol; 2013; 65(1):11-7. PubMed ID: 24180127
[TBL] [Abstract][Full Text] [Related]
20. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
Torres-Maravilla E; Carvalho FA; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Barbut F; Langella P; Bermúdez-Humarán LG; Waligora-Dupriet AJ
Benef Microbes; 2024 Apr; 15(3):293-310. PubMed ID: 38677716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
